Concepedia

Kathleen Kemmer

KK

24

Publications

3.9K

Citations

18

H-Index

1992

Active since

Affiliations

Oregon Health & Science University(Current)

The University of Texas MD Anderson Cancer Center

University of Pennsylvania

University of Alabama at Birmingham

University of California, San Francisco

Kathleen Kemmer is an author at Oregon Health & Science University specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

1992–2021

24

Publications

24

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

Rita Nanda, Minetta C. Liu, Christina Yau et al. · JAMA Oncology · 2020 · 672 citations · Full text

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

, , +10

Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele et al. · New England Journal of Medicine · 2016 · 543 citations · Full text

Adaptive Randomization of Neratinib in Early Breast Cancer

John W. Park, Minetta C. Liu, Douglas Yee et al. · New England Journal of Medicine · 2016 · 453 citations · Full text

KIT Mutations Are Common in Testicular Seminomas

Kathleen Kemmer, Christopher L. Corless, Jonathan A. Fletcher et al. · American Journal Of Pathology · 2004 · 319 citations · Full text

, , +7

Rows per page

1–5 of 24